Monoclonal Gammopathy
📧 Sign up to get email alerts when something new happens for Monoclonal Gammopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Isatuximab in Patients With Monoclonal Gammopathy of Renal Significance [Phase 2]
Phase 2 clinical trial evaluating isatuximab in patients with monoclonal gammopathy of renal significance is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: Rifaximin in Patients With Monoclonal Gammopathy [Phase 1]
Phase 1 clinical trial evaluating rifaximin in patients with monoclonal gammopathy; status is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Multi-center Screening for Serum M Protein
A multi-center screening trial is planned to screen for serum M protein in subjects with Monoclonal gammopathy and Multiple myeloma; recruit…
-
CLINICAL_TRIALS trial_result · 2024-08-19Clinical Trial Update: Monoclonal Gammopathy With Clinical Significance in Patients With and Without Haematological Malignancies in Finistère Between 2012 and 2017 (GammaClinik)
Completed clinical trial investigating monoclonal gammopathy with clinical significance in patients with and without hematologic malignancie…
-
CLINICAL_TRIALS research · 2024-07-09Clinical Trial Update: Screening for Monoclonal Gammopathy in Individuals Undergoing Physical Examinations Using iMS-LC Assay Technology.
A clinical trial update describes a screening study using iMS-LC assay technology to detect monoclonal gammopathy and M-protein during physi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2020-09-21Clinical Trial Update: Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat [Phase 4]
A Phase 4 trial investigating antigen-lipid–driven monoclonal gammopathies targeting epicardial fat has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-08-25Clinical Trial Update: Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing In Gammopathy Patients [Phase 1]
Phase 1 trial evaluating the efficacy of repeated dosing with a high-dose influenza vaccine in patients with gammopathy has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Prognostic Study of Markers of Angiogenesis and Coagulability in Patients With Monoclonal Gammopathy [NA]
Clinical trial update reporting completion of a prognostic study of angiogenesis and coagulability markers in patients with monoclonal gammo…